United States Patent and Trademark Office OG Notices: 16 September 2003

Date            Type of         Proceeding
Issued          Case (1)        or App'n No.            Party/Parties

8-15            OPP             124,856                 Unimed
                                                        Pharmaceuticals,
                                                        Inc. v. StarCor
                                                        Pharmaceuticals,
                                                        Inc.


                                Opposer's/              Applicant's/
                                Petitioner's            Respondent's
                TTAB            Mark and                Mark and
Issue           Decision        Goods/Services          Goods/Services

2(d)            Opposition      "ANADROL"               "ANDROL XL"
                Sustained       [steroid                [non-prescription
                                hormones];              nutritional
                                "ANDROGEL" and          supplement,
                                "ANDRACTIM"             namely, extended
                                [both marks for a       release
                                pharmaceutical          formulation of
                                preparation for         androstenedione]
                                the treatment of
                                testosterone
                                deficiency and/or
                                HIV wasting
                                syndrome]


Mark and                                        Citable as
Goods Cited by                                  Precedent
Examining Atty.                                 of TTAB

                                                No


(1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT
USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION
TO DISMISS; (MR)=MOTION TO REOPEN